Cancer
EXActDNA-003
Breast Cancer
Breast Cancer Clinical Validation Study to Predict Recurrence of High-Risk Early Breast Cancer Treated With Neoadjuvant Therapy Using a Bespoke Circulating Tumor DNA Assay to Detect Molecular Residual Disease
Contact Research Team:
[email protected]
Site principal investigator:
Whitney Hensing, MD
Learn more about this study:
NCT06401421